We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Acino and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.
Necessary Cookies Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics Cookies
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug...
Tuesday 10th June 2025
Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company...
Leadership Announcements and New Arcera Structure
Monday 2nd December 2024
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
Acino signs an exclusive agreement with LG Chem for Novel Treatments for...
Wednesday 24th July 2024
Acino will market, commercialize, and distribute Hyruan One® in Brazil, and Zemiglo® and Zemimet® SR (Zemiduo® SR in Mexico) in...
Acino signs an exclusive licensing and supply agreement with Allecra Therapeutics in...
Monday 24th June 2024
Acino will distribute Allecra’s novel antibiotic drug EXBLIFEP® (cefepime/enmetazobactam) within the Republic of South Africa and the member states of...
Acino signs an exclusive license agreement with Supernus in Latin America
Tuesday 7th May 2024
Acino will collaborate with Supernus to develop and commercialize products for the treatment of diseases of the central nervous system...
Acino announces new regional leadership and hub to deliver on expanded presence...
Tuesday 2nd April 2024
Joel Barlan has been appointed as Head of the LATAM region. Mexico City will now serve as a regional hub...
Acino appoints Samir El Nasharty as Chief Operations Officer
Monday 25th March 2024
Appointment of Samir El Nasharty as Chief Operations Officer and member of Acino’s Executive Committee, effective 1 April 2024.
Acino signs an exclusive license agreement with SERB Pharmaceuticals in Latin America
Wednesday 20th March 2024
We are collaborating to bring an important orphan drug for cancer patients to Latin America.
Acino Completes Acquisition of M8 Pharmaceuticals Significantly Expanding Presence and Capabilities in...
Monday 4th December 2023
Acino will enhance its presence in Latin America and strengthen its business through new partnerships, innovative and proven portfolio and...
Acino Significantly Expands Presence and Capabilities in Latin America Through Acquisition of...
Wednesday 20th September 2023
Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets.
Latest News
Stay up-to-date with Acino’s most recent updates.
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug...
Tuesday 10th June 2025
Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company...
Acino achieves Level 1 B-BBEE status in South Africa for the sixth...
Wednesday 21st May 2025
For the sixth consecutive year, Acino has achieved Level 1 Broad-Based Black Economic Empowerment (B-BBEE) contributor status in South Africa.
Acino Recognized Among Ukraine’s Top 50 Best Employers — Again!
Tuesday 29th April 2025
Forbes Ukraine, in collaboration with robota.ua, has once again included Acino in its list of Ukraine's Top 50 Best Employers.
Top Employer 2025: Acino South Africa achieves certification for the fourth consecutive...
Wednesday 29th January 2025
We are delighted to announce that Acino South Africa has been recognised as a Top Employer for 2025, marking the...
Thriving Through Change: the Thrilling Story of Maryna Larionova
Friday 13th December 2024
Maryna Larionova joined Acino Ukraine as an Accountant in August 2017, during a transformative period in her life. Her journey...
Leadership Announcements and New Arcera Structure
Monday 2nd December 2024
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
From Office Assistant to Senior Supply & Demand Officer: Mohammed’s 20-Year Career...
Thursday 17th October 2024
Mohammed Iqbal stands as a pillar of dedication at Acino. His long-standing tenure is a testament to the inspiring work...
Quality, Efficiency, Safety: Pharma Start Production Site in Ukraine Confirms EU GMP...
Tuesday 8th October 2024
The Acino production site, Pharma Start, in Ukraine has successfully completed an EU GMP audit.
Acino Publishes Second Annual Sustainability Report
Tuesday 1st October 2024
Report underscores Acino’s continued commitment to Environmental, Social, and Governance goals, including a firm commitment to reaching full carbon neutrality...
Acino Recognizes World Heart Day 2024
Sunday 29th September 2024
Acino reaffirms its commitment to advancing cardiovascular health in emerging markets and beyond.
Media contacts
Do you need to get in touch with us? Reach out to our media team with your enquiries.
